Peer Review Committee for Immunology and Blood Cell Development (IBCD)

Areas Reviewed

• Immune responses to cancer including active and passive immune therapies for cancer, adoptive transfer of autologous or allogeneic hematopoietic cells, and targeted delivery of toxic payloads
• Immune tolerance and hematopoiesis
• Molecular, structural, biochemical, and biophysical aspects of the immune system including cell types, cytokines, antigen processing, antibody molecules, and deficiencies

Committee members are being determined and will be announced early 2021.